The increasing prevalence of obesity, insulin resistance, and the metabolic syndrome has significant implications for the future of chronic liver disease. The resultant increase in the number of patients with nonalcoholic fatty liver disease (NAFLD) is expected to translate into increased numbers of patients with end-stage liver disease (cirrhosis), liver failure, and hepatocellular carcinoma. ...

Background of the Study: It is an imaging technology sensitive to tissue stiffness that was first described in 1990s. Nonalcoholic fatty liver disease (NAFLD) increasingly common Western nations world. most form chronic disease, affecting about one-quarter population, United States. Materials and Methods: Prospective studies 100 patients with clinical impression alcoholic were examined by Phili...

Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are the leading causes of hepatic fibrosis liver-related mortality worldwide, despite efficient hepatitis B C antiviral therapies that have dramatically lowered load. Although significant efforts been exerted to understand molecular basis pathogenesis, there currently few therapeutic alternatives available for NAFL...